WallStSmart

GE HealthCare Technologies Inc. (GEHC)vsNeogen Corporation (NEOG)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

GE HealthCare Technologies Inc. generates 2306% more annual revenue ($21.27B vs $884.00M). GEHC leads profitability with a 9.3% profit margin vs -6.3%. NEOG appears more attractively valued with a PEG of 0.66. GEHC earns a higher WallStSmart Score of 65/100 (C+).

GEHC

Buy

65

out of 100

Grade: C+

Growth: 6.0Profit: 6.5Value: 5.7Quality: 4.5
Piotroski: 2/9Altman Z: 1.34

NEOG

Hold

44

out of 100

Grade: D

Growth: 4.0Profit: 2.0Value: 7.7Quality: 7.0
Piotroski: 5/9Altman Z: 1.24
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for GEHC.

NEOGUndervalued (+80.7%)

Margin of Safety

+80.7%

Fair Value

$55.64

Current Price

$12.26

$43.38 discount

UndervaluedFair: $55.64Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

GEHC1 strengths · Avg: 8.0/10
P/E RatioValuation
16.3x8/10

Attractively priced relative to earnings

NEOG2 strengths · Avg: 9.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

PEG RatioValuation
0.668/10

Growing faster than its price suggests

Areas to Watch

GEHC4 concerns · Avg: 2.8/10
PEG RatioValuation
1.774/10

Expensive relative to growth rate

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Free Cash FlowQuality
$-617.00M2/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth
1.342/10

Distress zone — elevated risk

NEOG4 concerns · Avg: 1.8/10
Return on EquityProfitability
-29.0%2/10

ROE of -29.0% — below average capital efficiency

EPS GrowthGrowth
-85.6%2/10

Earnings declined 85.6%

Altman Z-ScoreHealth
1.242/10

Distress zone — elevated risk

Profit MarginProfitability
-6.3%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : GEHC

The strongest argument for GEHC centers on P/E Ratio.

Bull Case : NEOG

The strongest argument for NEOG centers on Price/Book, PEG Ratio. PEG of 0.66 suggests the stock is reasonably priced for its growth.

Bear Case : GEHC

The primary concerns for GEHC are PEG Ratio, Piotroski F-Score, Free Cash Flow.

Bear Case : NEOG

The primary concerns for NEOG are Return on Equity, EPS Growth, Altman Z-Score.

Key Dynamics to Monitor

GEHC profiles as a value stock while NEOG is a turnaround play — different risk/reward profiles.

NEOG carries more volatility with a beta of 1.79 — expect wider price swings.

NEOG is growing revenue faster at 6.5% — sustainability is the question.

NEOG generates stronger free cash flow (5M), providing more financial flexibility.

Bottom Line

GEHC scores higher overall (65/100 vs 44/100). NEOG offers better value entry with a 80.7% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

GE HealthCare Technologies Inc.

HEALTHCARE · MEDICAL DEVICES · USA

GE HealthCare Technologies Inc. provides medical technology, pharmaceutical diagnostics, and digital solutions in the United States. The company is headquartered in Chicago, Illinois.

Neogen Corporation

HEALTHCARE · MEDICAL DEVICES · USA

Neogen Corporation, develops, manufactures and markets various products for food and animal safety worldwide. The company is headquartered in Lansing, Michigan.

Visit Website →

Want to dig deeper into these stocks?